Free Online CME

Primary Vasculitides:
Best Practices and Future Advances

Print this Content

 

Cleveland Clinic R.J. Fasenmyer Center for Clinical Immunology presents Primary Vasculitides: Best Practices and Future Advances online series featuring an update on the current standard of care and management of patients with primary vasculitides. Advances and future development in the treatment of primary vasculitides will be shared by the experts in this field.

Webcasts

CNS Vasculitis: Diagnostic Update
Leonard H. Calabrese, DO
Release Date:   July 12, 2017
Expiration Date:   July 12, 2019
Estimated Time:   45 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine
Could EGPA be Treated with Biologics?
Michael E. Wechsler, MD, MMSc
Release Date:   June 29, 2017
Expiration Date:   June 29, 2019
Estimated Time:   30 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine
EGPA: Look Carefully at the Heart
W.H. Wilson Tang, MD
Release Date:   June 29, 2017
Expiration Date:   June 29, 2019
Estimated Time:   15 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine
Release Date:   June 12, 2017
Expiration Date:   June 12, 2019
Estimated Time:   30 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine
Release Date:   June 12, 2017
Expiration Date:   June 12, 2019
Estimated Time:   30 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine
GPA and MPA: Future Outlook
Ulrich Specks, MD
Release Date:   June 12, 2017
Expiration Date:   June 12, 2019
Estimated Time:   45 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine
EGPA
Rula Hajj-Ali, MD
Release Date:   June 12, 2017
Expiration Date:   June 12, 2019
Estimated Time:   30 minutes
Type:  Webcast
Technical Requirements: Flash Player
Specialties:  Rheumatology, Internal Medicine


Series Objectives

  1. Recognize the signs and symptoms of systemic vasculitic diseases in patients presenting with immunologic-associated conditions.
  2. Summarize efficacy and side effect data on use of conventional immunosuppressive agents to treat systemic vasculitis.
  3. Critically appraise the efficacy and side effect profiles, indications, and patient selection criteria for biologics in patients with systemic vasculitis.
  4. Provide an analytical review of the presentation, diagnosis, and treatment of CNS vasculitis.

Target Audience

This online series is directed towards rheumatologists, nephrologists, pulmonologists, dermatologists, neurologists, allergists, immunologists, and advanced practice clinicians interested in vasculitis.

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, OH

Rula Hajj-Ali, MD
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Associate Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Carol Langford, MD, MHS
Harold C. Schott Endowed Chair in Rheumatic and Immunologic Diseases
Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH